Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular markers to predict response to therapy.

Seminars in oncology - 1 Aug 2013

Garcia-Donas Jesus, Rodriguez-Antona Cristina, Jonasch Eric

Abstract excerpt

Currently approved treatments for metastatic renal cell carcinoma (RCC) include vascular endothelial growth factor (VEGF)-blocking agents, mammalian target of rapamycin (mTOR) inhibitors, and cytokine therapy. In the near future, we are likely to add immune checkpoint blocking agents to this list...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bevacizumab
Share to Carbonic Anhydrases
Share to Indazoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplastic Cells, Circulating

Share to Niacinamide

Share to Phenylurea Compounds

Share to Sorafenib

Share to Sunitinib

Source

Identifiers

PMID: 23972708
DOI: 10.1053/j.seminoncol.2013.05.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23972708-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular markers to predict response to therapy.PMID 23972708Read ↗

Molecular biomarkers in advanced renal cell carcinoma.Semantic proximity Read ↗

Biomarkers in renal cancer.Semantic proximity Read ↗

[Biomarkers of response to molecular targeted therapy in renal cell carcinoma].Semantic proximity Read ↗

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.Semantic proximity Read ↗

Prognostic and predictive biomarkers in renal cell carcinoma.Semantic proximity Read ↗

From bench to bedside: current and future applications of molecular profiling in renal cell carcinomaSemantic proximity Read ↗

Identification of novel biomarkers in renal cell carcinomaSemantic proximity Read ↗

Kidney cancer pathology in the new context of targeted therapy.Semantic proximity Read ↗

Biomarkers of renal cell carcinomaSemantic proximity Read ↗

Use of molecular markers for predicting therapy response in cancer patients.Semantic proximity Read ↗

Prognostic models and algorithms in renal cell carcinoma.Semantic proximity Read ↗

Biomarkers in clear cell renal cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.